Metabotropic Glutamate Receptor 3 Is Associated with Heroin Dependence but Not Depression or Schizophrenia in a Chinese Population

Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia

(2011) Jeffrey R. Bishop et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Effects of Metabotropic Glutamate Receptor 3 Genotype on Phonetic Mismatch Negativity

(2011) Yuki Kawakubo et al.   PLoS One

Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction

(2010) Khaled Moussawi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

N-Acetylcysteine reverses cocaine-induced metaplasticity

(2009) Khaled Moussawi et al.   NATURE NEUROSCIENCE

The glutamate homeostasis hypothesis of addiction

(2009) Peter W. Kalivas   NATURE REVIEWS NEUROSCIENCE

N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats

(2009) Zheng-Xiong Xi et al.   NEUROPHARMACOLOGY

Association analysis of Group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population

(2009) Tomoko Tsunoka et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression

(2008) Anton Y. Bespalov et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Metaplasticity: tuning synapses and networks for plasticity

(2008) Wickliffe C. Abraham   NATURE REVIEWS NEUROSCIENCE

Replication study and meta-analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case-control population

(2007) Talal Albalushi et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS